Prognosis panyakik Alzheimer umumnyo buruak, karano panyakik ko adolah kondisi progresif jo degeneratif nan indak ado ubeknyo.
Tingkek parkambangan baragam dari urang ka urang, tapi panyakik ko biasonyo batambah buruak dari wakatu ka wakatu, manyababkan panurunan kamampuan kognitif jo fisik.
Samantaro panyakiknyo bakambang, individu dapek mangalami ilang ingek, kesulitan jo bahaso jo komunikasi, disorientasi, jo parubahan suasana hati jo parilaku.
Akhianyo, inyo mungkin indak dapek lai manjaga dirinyo surang dan paralu bantuan sapanuah wakatu.
Rato-rato umua iduik sasudah didiagnosis adolah sakitar 8-10 taun, tapi iko dapek bavariasi sacaro laweh tagantuang pado umua individu, kasihatan umum, jo faktor lainnyo.
Walaupun indak ado ubeknyo, pangobatan jo terapi dapek mambantu mangalola gejala jo maningkekan kualitas iduik bagi urang nan punyo panyakik Alzheimer.
Kaldjian LC: Survival versus prognosis in Alzheimer disease. Ann Intern Med. 2004, 141 (7): 575; author reply 575.
Mayeux R, Stern Y, Sano M: Heterogeneity and prognosis in dementia of the Alzheimer type. Bull Clin Neurosci. 1985, 50 (): 7-10.
DeKosky ST, Golde T: Cerebrospinal Biomarkers in Alzheimer Disease-Potential Roles as Markers of Prognosis and Neuroplasticity. JAMA Neurol. 2016, 73 (5): 508-10.
Yaffe K: Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results. JAMA. 2010, 304 (17): 1952-3.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Malpetti M, Joie R, Rabinovici GD: Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials. J Nucl Med. 2022, 63 (6): 830-832.
Schaeffer EL, Figueiro M, Gattaz WF: Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo). 2011, 66 Suppl 1 (): 45-54.
Bhagwat N, Pipitone J, Voineskos AN, Chakravarty MM: An artificial neural network model for clinical score prediction in Alzheimer disease using structural neuroimaging measures J Psychiatry Neurosci. 2019, 44 (4): 246-260.
Vermunt L, van Paasen AJL, Teunissen CE, Scheltens P, Visser PJ, Tijms BM: Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal. Neurology. 2019, 92 (23): e2699-e2705.
Raji MA, Brady SR: Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. Ann Pharmacother. 2001, 35 (9): 1024-7.
['Disclaimer: medis']
['Situs web iko hanyo digunokan untuak tujuan pandidikan jo informasi sajo dan indak mambari nasehat medis atau layanan profesional.']
['Informasi nan disadioan indak buliah digunoan untuak mandiagnosis atau maubek masalah kasihatan atau panyakik, dan urang nan mancari nasehat medis pribadi harus bakonsultasi jo dotor nan balisensi.']
['Tolong diingek jaringan saraf nan manghasilkan jawaban untuak pertanyaan, khususnyo indak akurat katiko datang ka isi numerik. contohnyo, jumlah urang nan didiagnosis jo panyakik tatantu.']
['Salalu mintak nasehat dotor atau panyadia kasihatan lain nan kualifikasi manganai kondisi medis. Jan pernah maabaikan nasehat medis profesional atau talambek dalam mamintaknyo dek karano sasuatu nan awak baco di situs web iko. Jiko awak sangko mungkin ado kaadaan darurat medis, hubungi 911 atau pai ka ruang gawat darurat paliang dakek lansuang. Indak ado hubungan dotor-pasien nan diciptaan dek situs web iko atau panggunoannyo. BioMedLib maupun karyawan, maupun kontributor situs web iko, indak ado malakukan representasi, jaleh atau tasuruak, manganai informasi nan disadioan di siko atau panggunoannyo.']
['Panyalasaian: hak cipta']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) manyadiokan jalan bagi pamilik hak cipta nan picayo bahwasanyo bahan nan muncul di Internet malangga haknyo manuruik hukum hak cipta AS. ']
['Jiko Sanak yakin jo yakin baso isi atau bahan nan tasadio dalam pautan ka situs web atau layanan kami malangga hak cipta Sanak, Sanak (atau agen Sanak) dapek mangirim kami pasan mamintak untuak manghapuih isi atau bahan tasabuik, atau mamblokir akses ka situs tasabuik. ']
['Kabar harus dikirim sacaro tulisan malalui surel (caliak bagian "Kontak" untuak alamat surel).']
['DMCA mamaraluan supayo pasan pasan palanggaran hak cipta nan didakwa tamasuak informasi barikuik: (1) deskripsi karya hak cipta nan manjadi subyek palanggaran nan didakwa; (2) deskripsi isi nan didakwa malanggar jo informasi nan cukuik untuak mamungkinkan kami untuak manamukan isi; (3) informasi kontak untuak Sanak, tamasuak alamat, nomor telepon jo alamat surel; (4) pernyataan Sanak baso Sanak punyo kayakinan baiak baso isi nan dikaduan indak diizinkan dek nan punyo hak cipta, atau agennyo, atau dek operasi hukum apo pun; ']
['(5) suatu pernyataan nan ditandotangani dek Sanak, jo hukuman sumpah palsu, baso informasi dalam notifikasi tu akurat jo Sanak punyo wewenang untuak manjalankan hak cipta nan dikatokan alah di langgar; ']
['dan (6) ciek tando tangan fisik atau elektronik dari pamilik hak cipta atau sasaurang nan punyo hak untuak batindak ateh namo pamilik hak cipta. ']
['Kok indak tamasuak sado informasi di ateh dapek manyababkan panundaan pangolahan aduan Sanak.']
['Kontak']
['Tolong kirim surel untuak pertanyaan/saran.']
What is prognosis of alzheimer?
The prognosis of Alzheimer's disease is generally poor, as it is a progressive and degenerative condition with no known cure.
The rate of progression varies from person to person, but the disease typically worsens over time, leading to a decline in cognitive and physical abilities.
As the disease progresses, individuals may experience memory loss, difficulty with language and communication, disorientation, and changes in mood and behavior.
Eventually, they may become unable to care for themselves and require full-time assistance.
The average life expectancy after diagnosis is around 8-10 years, but this can vary widely depending on the individual's age, overall health, and other factors.
While there is no cure, treatments and therapies can help manage symptoms and improve quality of life for those with Alzheimer's disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Sakitarnyo']
['BioMedLib manggunokan komputer otomatis (algoritma machine-learning) untuak mambuek pasangan pertanyaan-jo-jawaban.']
['Kami mamulai jo 35 juta publikasi biomedis dari PubMed/Medline. juo, laman web dari RefinedWeb.']